Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Barnes, Thomas R.E.
and
Edwards, J. Guy
1993.
Antipsychotic Drugs and their Side-Effects.
p.
213.
Figueras, Albert
and
Capellà, Dolors
1993.
Vol. 17,
Issue. ,
p.
49.
Byrne, Peter
1997.
Psychiatric Stigma: Past, Passing and to Come.
Journal of the Royal Society of Medicine,
Vol. 90,
Issue. 11,
p.
618.
Arango, Celso
Adami, Helene
Sherr, Jay D.
Thaker, Gunvant K.
and
Carpenter, William T.
1999.
Relationship of Awareness of Dyskinesia in Schizophrenia to Insight Into Mental Illness.
American Journal of Psychiatry,
Vol. 156,
Issue. 7,
p.
1097.
Chong, Siow-Ann
Remington, Gary
Mahendran, Rathi
and
Chua, Hong-Choon
2001.
Awareness of Tardive Dyskinesia in Asian Patients with Schizophrenia.
Journal of Clinical Psychopharmacology,
Vol. 21,
Issue. 2,
p.
235.
Pasricha, P Jay
Pehlivanov, Nonko
Sugumar, Aravind
and
Jankovic, Joseph
2006.
Drug Insight: from disturbed motility to disordered movement—a review of the clinical benefits and medicolegal risks of metoclopramide.
Nature Clinical Practice Gastroenterology & Hepatology,
Vol. 3,
Issue. 3,
p.
138.
Emsley, R.
Niehaus, D.J.H.
Oosthuizen, P.P.
Koen, L.
Chiliza, B.
and
Fincham, D.
2011.
Subjective awareness of tardive dyskinesia and insight in schizophrenia.
European Psychiatry,
Vol. 26,
Issue. 5,
p.
293.
van Harten, Peter N.
and
Tenback, Diederik E.
2011.
Pathophysiology, Pharmacology, and Biochemistry of Dyskinesia.
Vol. 98,
Issue. ,
p.
187.
Bakker, P. Roberto
de Groot, Izaäk W.
van Os, Jim
van Harten, Peter N.
and
Priller, Josef
2011.
Long-Stay Psychiatric Patients: A Prospective Study Revealing Persistent Antipsychotic-Induced Movement Disorder.
PLoS ONE,
Vol. 6,
Issue. 10,
p.
e25588.
Caroff, Stanley N.
Campbell, E. Cabrina
and
Carroll, Benjamin
2017.
Pharmacological treatment of tardive dyskinesia: recent developments.
Expert Review of Neurotherapeutics,
Vol. 17,
Issue. 9,
p.
871.
Caroff, Stanley N.
Ungvari, Gabor S.
and
Cunningham Owens, David G.
2018.
Historical perspectives on tardive dyskinesia.
Journal of the Neurological Sciences,
Vol. 389,
Issue. ,
p.
4.
Stegmayer, Katharina
Walther, Sebastian
and
van Harten, Peter
2018.
Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies.
CNS Drugs,
Vol. 32,
Issue. 2,
p.
135.
Strassnig, Martin
Rosenfeld, Amie
and
Harvey, Philip D.
2018.
Tardive dyskinesia: motor system impairments, cognition and everyday functioning.
CNS Spectrums,
Vol. 23,
Issue. 6,
p.
370.
Niemann, Nicki
and
Jimenez-Shahed, Joohi
2019.
Deutetrabenazine in the Treatment of Tardive Dyskinesia.
Neurodegenerative Disease Management,
Vol. 9,
Issue. 2,
p.
59.
Owens, David Cunningham
2019.
Tardive dyskinesia update: the syndrome.
BJPsych Advances,
Vol. 25,
Issue. 1,
p.
57.
Caroff, Stanley N.
Leong, Shirley H.
Roberts, Christopher
Berkowitz, Rosalind M.
and
Campbell, E. Cabrina
2020.
Cumulative Burden of Illness in Veterans With Tardive Dyskinesia and Serious Mental Disorders.
Journal of Clinical Psychopharmacology,
Vol. 40,
Issue. 1,
p.
38.
Rekhi, Gurpreet
Tay, Jenny
and
Lee, Jimmy
2022.
Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia.
Journal of Psychopharmacology,
Vol. 36,
Issue. 2,
p.
183.
Hauser, Robert A.
Meyer, Jonathan M.
Factor, Stewart A.
Comella, Cynthia L.
Tanner, Caroline M.
Xavier, Rose Mary
Caroff, Stanley N.
and
Lundt, Leslie
2022.
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
CNS Spectrums,
Vol. 27,
Issue. 2,
p.
208.
Warren, Barbara
Vanderhoef, Dawn
and
Johnson, Jessica
2022.
VMAT2 Inhibitors for the Treatment of Tardive Dyskinesia.
Issues in Mental Health Nursing,
Vol. 43,
Issue. 1,
p.
22.
eLetters
No eLetters have been published for this article.